Parkinson’s UK invests in clinical trial of a potential treatment that could protect brain cells Date 2 July 2024
Parkinson's UK invests in first trial of pioneering treatment in people with Parkinson’s Date 1 July 2024
Further evidence that Parkinson's starts in the gut Date 24 November 2016 An abnormal protein normally found in brain cells affected in Parkinson's can move from the gut to the brain, according to new research.
New drug treatment Opicapone launches in UK Date 18 October 2016 A new drug treatment for Parkinson's, opicapone, has launched in the UK. It could prolong the effect of levodopa and reduce the number of tablets required.
New research highlights importance of cardiovascular health in Parkinson's Date 29 September 2016 New research shows that people recently diagnosed with Parkinson's who are at high or medium risk of cardiovascular disease tend to have more problems with walking and memory.
Study shows potential benefit for caffeine in Parkinson's Date 20 September 2016 A new clinical study published in the journal Parkinsonism and Related Disorders links higher caffeine consumption to slower development of Parkinson's symptoms after diagnosis.
Understanding the link between head injury and Parkinson's risk Date 12 July 2016 New research suggests that severe head injury, which causes loss of consciousness, could be linked to increased risk of developing Parkinson's.
7 major pharma companies sign up to Parkinson's initiative Date 23 February 2016 7 of the world’s largest pharmaceutical companies have signed up to a ground-breaking new initiative to improve clinical trials for Parkinson's.
Common dementia drug could improve Parkinson's symptoms Date 12 January 2016 Researchers at the University of Bristol have discovered that a common dementia drug, rivastigmine, could reduce falls in people with Parkinson's.